The global glycobiology market is expected to reach USD 4,671 Million by 2030, at a CAGR of 13% during the forecast period 2021 to 2030. The glycobiology market has grown due to the increasing demand for government funding for glycobiology research and growing R&D expenditure by pharmaceutical and biotechnology companies.